Additional value will come later when the genome is fully annotated. The fully annotated sequence will serve as a blueprint for the C1 host strain and will facilitate further development of C1-based technology as a platform for discovery and production of a wider variety of proteins from diverse s their ces, including high-value therapeutics.
With an annotated genome, the genes and proteins involved with these various processes can be identified, isolated, and ultimately manipulated to provide a system of optimal utility.
Leading biological firm Dyadic International Inc, is engaged in the development, produces and sale of biological products (proteins, enzymes, peptides and other bio-molecules), as well as the licensing of its enabling proprietary technology to business collaborators for the discovery, development and manufacture of biological products from genes. Dyadic markets its products and services for applications in the textile, chemical, agricultural, pulp & paper, pharmaceutical, biotechnology and other industries, using its proprietary C1 Host Technology and C1 Expression and Screening Systems for the discovery, development and production of biological products.
Florida based Dyadic, founded in 1979, has significant experience in the discovery, development, manufacturing and commercialization of specialty enzymes and chemicals for the textile, animal feed, and paper and pulp industries.